About the editors

Chief Editor Lisa Hutchinson, BSc, PhD

Lisa obtained a first class honours BSs degree in Biochemistry from University College London, and received her PhD from the Institute of Cancer Research, London, under the supervision of Dr Michael J. Fry, where her research focused on the biochemical analysis of components of the Wg/Wnt signalling pathway in breast cancer. Lisa then left the bench to pursue her career in publishing, and in 1999 joined Current Science Ltd as Assistant Editor of the journal Breast Cancer Research. She was promoted to the Editor after 1 year. In 2002, she joined Wells Healthcare Limited as Senior Editor working on a number of projects in the fields of hepatology, diabetes, chronic wound care, and drug addiction. Lisa joined the Nature Reviews department in 2004 and has been the Chief Editor of Nature Reviews Clinical Oncology since that time.

Senior Editor David Killock, BSc, ARCS, PhD

David obtained a BSc in Biochemistry from the Imperial College London. His undergraduate studies included a 1-year sandwich placement working in a GlaxoSmithKline drug metabolism and pharmacokinetics laboratory focused on metabolite identification. Subsequently, David became a Research Assistant working within the Membrane/Cytoskeletal Signalling Group of the National Heart and Lung Institute Cardiovascular Sciences Department, Imperial College London, and went on to conduct a PhD focused on mechanisms of leukocyte trafficking, under the guidance of Dr Aleksandar Ivetic. After moving with Dr Ivetic to King's College London Cardiovascular Division in 2009, David conducted a short post-doctoral project before moving out of the laboratory and into medical publishing as a Locum Associate Editor at Nature Reviews Rheumatology. Since joining Nature Reviews, he has worked on other titles, including Nature Reviews Urology, and joined the Nature Reviews Clinical Oncology team in 2014.

Associate Editor Diana Romero, PhD

Diana obtained her PhD in Biochemistry from the Universidad Autonoma de Madrid (Spain), where she studied the role of TGF-β in cancer progression in Miguel Quintanilla's group. She joined Calvin Vary's laboratory at Maine Medical Center Research Institute (US) for her first postdoctoral project, which was related to TGF-β receptor signalling and prostate cancer. In 2010 she moved to Robert Kypta's group at Imperial College London (UK) as a postdoc. While maintaining her interest in prostate cancer, her project focused on Dickkopf-3 signalling. Diana joined the Nature Reviews Clinical Oncology team in July 2015.

Associate Editor Peter Sidaway, BSc, PhD

After studying pharmacology at the University of Newcastle Upon Tyne, UK, Peter commenced his doctoral studies in retinal neuroscience at the University of East Anglia, UK. After obtaining his PhD, he moved to the University of Birmingham, UK, where he became interested in autonomic neuroscience and neuropharmacology relating to the control of pelvic organ function. Peter further pursued these research interests as a Japan Society for the Promotion of Science overseas research fellow, before joining Nature Clinical Reviews as a Cross-Title Associate Editor in April 2014. He now works as an Associate Editor shared between Nature Reviews Urology and Nature Reviews Clinical Oncology.

Contact details

The Nature Reviews Clinical Oncology team is based in the London editorial office:

Postal address

Nature Reviews Clinical Oncology, The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom.



Extra navigation


Subscribe to Nature Reviews Clinical Oncology